KLRA - CIK 0002096997
The table below shows Kailera Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | -$68.31M | -$18.20M |
| Capital expenditure | - | - |
| Investing cash flow | $22.85M | -$54.44M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | -$2.98M | $0.00 |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.